Related Experiment Video
Updated: Aug 18, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
Published on: September 9, 2015
BRL.8988 (talampicillin), a well-absorbed oral form of ampicillin
Abstract:
The phthalidyl ester (BRL.8988, talampicillin) of ampicillin gave serum levels in man two and a half times those obtained with ampicillin itself.
Insights
Talampicillin, a phthalidyl ester prodrug of ampicillin, significantly enhances ampicillin bioavailability. This ester form resulted in 2.5 times higher ampicillin serum concentrations in humans compared to the parent drug.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Medicinal Chemistry
Background:
- Ampicillin is a widely used penicillin-class antibiotic.
- Improving ampicillin's oral bioavailability remains a key challenge in antibiotic therapy.
Purpose of the Study:
- To evaluate the pharmacokinetic profile of talampicillin, a novel ampicillin ester.
- To compare serum ampicillin levels achieved with talampicillin versus ampicillin.
Main Methods:
- Administration of talampicillin and ampicillin to human subjects.
- Measurement of serum ampicillin concentrations over time.
Main Results:
- Talampicillin administration resulted in significantly higher ampicillin serum levels.
- Serum concentrations were approximately 2.5 times greater with talampicillin compared to ampicillin.
Conclusions:
- Talampicillin demonstrates improved pharmacokinetic properties over ampicillin.
- This phthalidyl ester prodrug offers a promising approach to enhance ampicillin efficacy.
Related Concept Videos
Production of Antibiotics
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Clinical Significance of Antibiotic Resistance
Antibiotic Selection
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
